Latest Strategic Investments News

Helloworld Travel reported a 4.1% rise in profit after tax for FY25 despite an 8.7% revenue decline, driven by strong growth in Wholesale and Inbound segments and strategic investments in technology and acquisitions.

Helloworld Travel Limited reported a mixed FY25 performance with an 8.6% decline in Total Transaction Value but a rise in underlying EBITDA, alongside a fully franked final dividend and a strategic acquisition in New Zealand.

Coles Group Limited reported solid FY25 results with strong supermarket growth, digital acceleration, and significant sustainability achievements. The company’s investments in automation and customer experience underpin its positive outlook for FY26.

IVE Group delivered a robust FY25 with a 69% jump in IFRS net profit, driven by margin gains and cost synergies, while guiding steady earnings for FY26 despite higher capital spending and relocation expenses.

Viva Energy's half-year results reveal a resilient Commercial segment offsetting pressures in Refining and Retail, as the company advances its retail transformation and cost synergy targets.

IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

AUB Group has reported a robust FY25 with a 17% rise in underlying net profit after tax and increased dividends, setting an optimistic tone for FY26 with growth guidance up to 13.4%.

Metals X Limited reported a robust half-year to June 2025 with profit after tax soaring 256% to $52.9 million, driven by higher tin sales and prices from its Renison joint venture. The company also progressed key projects and deepened strategic investments while reinforcing its ESG and safety frameworks.